Astrazeneca Pharma India Ltd

Astrazeneca Phar | 506820

Market Closed

₹9,140.00

+₹0.00 (+-0.14%)

As on 19/11/25, 2:19 AM

Market Cap22,882.5 CR

Current Price₹9,140

High / Low₹10,691 / 6,220

PE Ratio---

Book Value₹---

Dividend Yield---

ROCE---

ROE23.63%

Face Value₹2.00

Current Vol.4,268

Average Vol.12,76,53,456

ISININE203A01020

PB Ratio---

Debt to Equity---

Net Profit Margin---

Operating Margin---

Stock cgart

Stock Performance

₹2,480₹2,490

₹2,500

Previous CloseToday's Open

₹1,800₹3,000

₹2,500

52W Low52W High

₹2,480Today's Open

₹2,490Previous Close

12,00,000Volume

₹1,80052W Low

₹3,00052W High

Ratios

📊

Consolidated data not available

Please try selecting a different data type

About Company

AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979
The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company
The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology
AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL
Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25
75% of the Company's issued and paid up equity share capital
Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company
AstraZeneca Pharmaceuticals AB Sweden
AstraZeneca Pharma India Limited (the Company') is a subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, which is an indirect subsidiary of AstraZeneca PLC, United Kingdom
The company expanded the installed capacity of Injectables during the year 2001 by 0

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

;

Technical Indicators

RSI46.18

SMA 209305.67

SMA 509173.81

SMA 1009015.94

SMA 2008591.47

SMA 109268.35

MACD_12_26_Days-1.11

EMA10Day9224.01

EMA20Day9247.06

EMA50Day9162.81

MACD_12_26_9_Days-40.39

EMA100Day8994.72

EMA200Day8555.85

Pivot Points

Volume Analysis

Growth Rate

📊

No Information Available

Growth Rate information is not available at this time.

All figures in ₹ Crores

📊

No Information Available

No profit & lossdata available

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

18 Nov 2025 12:00 am

AstraZeneca partners with Sun Pharma for second SZC brand in India

17 Nov 2025 12:00 am

Astrazeneca Pharma and Sun Pharma form second brand partnership

Record Date

Corporate Action

Information

Announcement Day

14 Aug 2025

AGM

28 Jul 2025

18 Jul 2025

Final Dividend (₹32)

Recommended Dividend of Rs. 32/- per equity share of Rs. 2/- each, subject to the approval of shareholders at the forthcoming Annual General Meeting of the Company Please find the enclosed intimation of the Company in relation to the captioned subject for your reference. (As Per BSE Announcement Dated on: 11.07.2025)

30 May 2025

08 Aug 2024

AGM

16 Jul 2024

05 Jul 2024

Final Dividend (₹24)

We wish to inform that at the meeting of Board of Directors of the Company held on May 27, 2024, the Board has recommended dividend of Rs. 24/- per equity share of Rs. 2/- each subject to the approval of the shareholders at the forthcoming AGM of the Company. Further to our intimation dated May 27, 2024, we wish to inform that the Record Date for determining the entitlement of the shareholders for the payment of Final Dividend for the financial year is July 5, 2024. The Final Dividend, if approved by the shareholders, shall be paid/ dispatched to the shareholders on or before September 6, 2024. (As Per BSE Announcement dated on 25.06.2024)

27 May 2024

14 Aug 2023

AGM

22 Jul 2023

14 Jul 2023

Final Dividend (₹16)

The Board of Directors of the Company at its Meeting held today i.e., May 30, 2023, inter alia, recommended Dividend of Rs. 16/- per equity share for the Financial Year 2022-23

30 May 2023

08 Aug 2022

AGM

15 Jul 2022

08 Jul 2022

Final Dividend (₹8)

AstraZeneca Pharma India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2022, inter alia, has recommended Final Dividend of Rs. 8/- per equity share for the financial year 2021-22. Further to our intimation dated May 26, 2022, we wish to inform that the Record Date for determining the entitlement of the shareholders for the payment of the Final Dividend for financial year 2021-22 is July 8, 2022. The Final Dividend, if approved by the shareholders, shall be paid/dispatched to the shareholders on or before September 6, 2022. (As Per BSE Announcement Dated on 27/06/2022)

26 May 2022

20 Aug 2021

Interim Dividend (₹2)

AstraZeneca Pharma India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2021, inter alia, has declared Interim Dividend of Rs. 2 per equity share for the financial year 2021-22.

09 Aug 2021

AGM

26 May 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
9,065			0
1,760	4,22,211	37	5	30	0	20.88%
6,475	1,71,898	69	11	59	0	23.41%
3,793	1,28,372	59	15	43	1	16.60%
1,515	1,22,349	22	4	19	0	19.21%
1,244	1,03,789	18	3	14	0	17.54%
2,047	93,506	22	5	17	0	14.56%
928	93,404	19	4	15	0	19.86%
2,224	91,800	53	6	35	0	14.39%
1,240	72,630	21	2	14	0	10.98%

Showing 10 of 125 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

Frequently Asked Questions

What is Share Price of Astrazeneca Pharma India Ltd?

The current share price of Astrazeneca Pharma India Ltd (Astrazeneca Phar) is ₹9140.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the 52-week high and low of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd has a 52-week high of ₹10691.00 and a 52-week low of ₹6220.00. This range shows the stock's price volatility over the past year.

What is the ROE of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd has a Return on Equity (ROE) of 23.63%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds.